53 related articles for article (PubMed ID: 1341001)
21. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
22. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
[TBL] [Abstract][Full Text] [Related]
23. [Cytogenetic and molecular aspects of Ph-positive leukemia].
Misawa S; Nishigaki H
Rinsho Ketsueki; 1991 Apr; 32(4):313-8. PubMed ID: 2067072
[TBL] [Abstract][Full Text] [Related]
24. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C
Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148
[TBL] [Abstract][Full Text] [Related]
25. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
26. Mixed lineage leukemia with cytogenetically unrelated abnormal clones.
Bardi G; Pandis N; Arsenis P; Stamatellou M; Dermitzaki K; Papanastasiou C; Tsakanikas S; Kallinikou-Maniatis A
Cancer Genet Cytogenet; 1989 Jul; 40(1):83-7. PubMed ID: 2758402
[TBL] [Abstract][Full Text] [Related]
27. Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.
Fleischman EW; Prigogina EL; Volkova MA; Frenkel MA; Zakhartchenko NA; Konstantinova LN; Puchkova GP; Balakirev SA
Hum Genet; 1981; 58(3):285-93. PubMed ID: 6948765
[TBL] [Abstract][Full Text] [Related]
28. Proliferation studies on chromosome preparations of bone marrow in hematological disease.
Walther JU; Pohl I; Rausch A; Fuehrer M
Oncol Rep; 2006 Oct; 16(4):893-9. PubMed ID: 16969511
[TBL] [Abstract][Full Text] [Related]
29. Childhood biphenotypic leukemia: detection of mixed lymphoid and myeloid populations in bone marrow specimens.
Schmitt-Gräff A; Jürgens H; Reifenhäuser A; Schwamborn D; Göbel U
Hum Pathol; 1988 Jun; 19(6):651-6. PubMed ID: 2837429
[TBL] [Abstract][Full Text] [Related]
30. De novo acute myeloid leukemia with near-pentaploidy: diploid karyotype and lymphoblastic phenotype at relapse.
Rund D; Ben-Neriah S; Yehuda O; Leizerowitz R; Okon E; Polliack A
Leuk Lymphoma; 1997 May; 25(5-6):585-91. PubMed ID: 9250831
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetics in childhood leukemias and malignant lymphomas.
Abe R; Maruyama Y
Indian J Pediatr; 1993; 60(2):203-10. PubMed ID: 8244495
[No Abstract] [Full Text] [Related]
32. Functional EP2 receptors on blast cells of patients with acute leukemia.
Denizot Y; Donnard M; Truffinet V; Malissein E; Faucher JL; Turlure P; Bordessoule D; Trimoreau F
Int J Cancer; 2005 Jun; 115(3):499-501. PubMed ID: 15688380
[No Abstract] [Full Text] [Related]
33. Ultrastructural cytochemical analysis of blastic transformation of chronic myelocytic leukemia.
Palakavongs P; Teichberg S; Vinciguerra V; Degnan TJ; Sinlaratana P
Blood; 1977 Apr; 49(4):535-47. PubMed ID: 191121
[TBL] [Abstract][Full Text] [Related]
34. A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies.
Teerenhovi L; Knuutila S; Ekblom M; Rossi L; Borgström GH; Tallman JK; Andersson L; de la Chapelle A
Blood; 1984 Nov; 64(5):1116-22. PubMed ID: 6207873
[TBL] [Abstract][Full Text] [Related]
35. Combined method for simultaneous morphology, immunophenotype and karyotype (MAC) in leukemias.
Chauffaille Mde L; Coutinho V; Yamamoto M; Kerbauy J
Sao Paulo Med J; 1997; 115(1):1336-42. PubMed ID: 9293114
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin: an unhealthy sleep remedy for ALL.
Burger JA
Blood; 2013 Jun; 121(24):4814-5. PubMed ID: 23766457
[TBL] [Abstract][Full Text] [Related]
37. Simplified method for the analysis of cellular karyotype and phenotype in leukemias.
Chauffaille Mde L; Coutinho V; Kerbauy J
Rev Paul Med; 1992; 110(3):97-101. PubMed ID: 1341001
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
[TBL] [Abstract][Full Text] [Related]
39. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
